Ross Leonard S 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Apr 2, 2019
Insider Transaction Report
Form 4
Ross Leonard S
Corporate Controller
Transactions
- Exercise/Conversion
Common Stock
2019-04-01$1.81/sh+5,000$9,050→ 79,452 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-04-01−5,000→ 0 totalExercise: $1.81Exp: 2019-06-25→ Common Stock (5,000 underlying)
Footnotes (1)
- [F1]The option was granted on 6/25/2009 and vested in four equal annual installments beginning on the first anniversary of the grant.